Listen Carefully: An Exploratory Study of the Association Between Listening Effort and Cognitive Function
Cognitive Impairment, Mild, Hearing Loss
About this trial
This is an interventional basic science trial for Cognitive Impairment, Mild
Eligibility Criteria
MCI group
Inclusion Criteria:
- Is 40-85 years old;
- Has no other significant neurological or psychiatric disease;
- Has normal hearing (0 - 25 dB thresholds from 250 -6 kHz) measured using PTA;
- Has normal or corrected to normal vision;
- Has an MCI diagnosis, according to Winblad criteria, with a score on the Mini Mental State Examination (MMSE) less than or equal to 26 (MMSE ≤ 26);
- Has a CDR = 0.5;
- Speaks Danish as native language
- (For part 2 of the study - hearing aid use) has a live-in informant.
Exclusion Criteria:
- Takes medication or treatment that could impact the pupillary dilation: eye drops (e.g. atropine or phenylephrine);
- Takes medication or treatment that could impact cognitive function;
- Abuses alcohol or drugs;
- Is unable to comply with study procedures.
Cognitively healthy group:
Inclusion criteria:
- Is 40-85 years old;
- Has a score above 26 on the Mini Mental State Examination (MMSE) (MMSE > 26);
- Has a CDR Global score = 0;
- Has no significant neurological or psychiatric disease;
- Has Normal hearing (0 - 25 dB thresholds from 250 -6 kHz) measured using PTA;
- Has Normal or corrected to normal vision;
- Speaks Danish as a native language.
Exclusion criteria:
- Meets the criteria for MCI (Winblad criteria) or dementia (ICD 10);
- Takes medication or treatment that could impact the pupillary dilation: eye drops (e.g. atropine or phenylephrine);
- Takes medication or treatment that could impact cognitive function;
- Abuses alcohol or drugs;
- Is unable to comply with study procedures.
Sites / Locations
- Copenhagen Memory Clinic, Rigshospitalet
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Mild Cognitive Impairment (MCI)
Cognitively Healthy
MCI is defined as an early stage of cognitive decline that lies between normal age-matched cognitive function and the onset of very mild forms of dementia, and is associated with a slight but noticeable decline in abilities such as memory and thinking skills. Listening effort testing (with pupillometry) and cognitive testing will be administered for this group - and after a 6-week period of hearing aid use, these measures will be re-tested.
This group is 40-85 years old and has no significant neurological or psychiatric disease. Listening effort testing (with pupillometry) and cognitive testing will be administered for this group - and after a 6-week period of hearing aid use, these measures will be re-tested.